-
Company Profile
![]()
aTyr Pharma Inc – Company Profile
ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company. It includes in discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company's ATYR1923 is a clinical-stage product candidate based on the resokine pathway which binds to the neuropilin-2 receptor harnesses immune engagement in interstitial lung diseases and other immune-mediated diseases. It also concentrates on research and development of the extracellular functionality of tRNA synthetases. ATyr Pharma also develops drugs for cancer, inflammation, neurodegenerative...
Add to Basket -
Company Profile
![]()
ImmunityBio Inc – Company Profile
ImmunityBio Inc (ImmunityBio), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company developing therapies for therapies for cancer and infectious diseases. The company product pipeline includes anktiva + BCG, anktiva + keytruda (pembrolizumab), aldox + anktiva + PD-L1 t-hank, anktiva + tri-ad5 vaccines, anktiva + bevacizumab + PD-L1 t-hank, anktiva + IBRX-042 vaccination, anktiva + M-ceNK and anktiva + CD19 t-haNK. ImmunityBio pipeline candidates treat bladder cancer, lung cancer, lynch syndrome, pancreatic cancer, glioblastoma, HPV, advanced Solid tumors, non-hodgkin...
Add to Basket -
Company Profile
![]()
Harpoon Therapeutics Inc – Company Profile
Harpoon Therapeutics Inc (Harpoon) is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The company’s pipeline products include HPN536 against ovarian cancer, HPN217 targeting Multiple Myeloma, HPN328 indicated for small cell lung cancer; and HPN601, is a protease-activated EpCAM targeting T cell engager for the treatment of solid tumors. It utilizes Tri-specific T cell activating construct (TriTAC) platform,...
Add to Basket -
Company Profile
![]()
Humacyte Inc – Company Profile
Humacyte Inc provides human tissue-based products for vascular disease that develops bioengineered human tissues, and organ systems of improving the lives of patients. The company is headquartered in Durham, North Carolina, the US.
Add to Basket -
Company Profile
![]()
Sonendo Inc – Company Profile
Sonendo Inc (Sonendo) is a medical technology company developing innovative and disruptive technologies to transform endodontics and dentistry treatments through Sound Science. Its products include gentle wave systems and TDO Software. Gentle Wave System is used for the treatment of the root canal system. GentleWave System mechanism is a combination of broad-spectrum acoustic energy and fluid dynamics to clean the complex anatomy of the root canal system. CleanFlow procedure instrument is the latest in GentleWave technology that cleans and disinfects...
Add to Basket -
Company Profile
![]()
Evelo Biosciences Inc – Company Profile
Evelo Biosciences Inc (Evelo Biosciences) is a biotechnology company. It develops orally delivered product candidates for the treatment of inflammatory diseases and cancer. The company pipeline products include EDP1815 and EDP2939 among others. Its product EDP1815 treats mild to moderate psoriasis EDP2939 in psoriasis. Evelo Biosciences is also evaluating novel therapies to treat chronic diseases and cancer. It has its operations in the US and the UK. Evelo Biosciences is headquartered in Cambridge, Massachusetts, the US.
Add to Basket -
Company Profile
![]()
Sonnet BioTherapeutics Holdings Inc – Company Profile
Sonnet BioTherapeutics Holdings Inc (Sonnet), formerly Chanticleer Holdings Inc, is an oncology-biotechnology company with a proprietary platform for innovating biologic drugs of single or bispecific, bifunctional action. The company’s pipeline program includes Son-1010(IL12-FHAB), Son-1210(IL12-FHAB), Son-1210(IL12-FHAB-1L15), Son-1410(IL18-FHAB-1L12), Son-3015(Anti-1L6-FHAB-Anti-TGFB), SON-080(Low-dose IL- 6). Its pipeline candidates treat solid tumors, platinum-resistant ovarian cancer, solid tumors, melanoma renal cancers, tumor and bone metastases, chemotherapy-induced peripheral neurotherapy and diabetic peripheral neuropathy. Sonnet harnesses its proprietary FHAB (Fully Human Albumin Binding) technology to discover biologic drugs with...
Add to Basket -
Company Profile
![]()
Harness Inc – Company Profile
Harness Inc is a developer of a software delivery platform. It offers cost management, service reliability management, continuous error tracking and security testing services. The company is headquartered in San Francisco, California, the US.
Add to Basket -
Product Insights
![]()
ECG Monitoring Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Electrocardiogram (ECG) Monitoring Equipment Pipeline Market Report Overview Electrocardiogram (ECG) Monitoring Equipment records the electrocardiogram (ECG) and is used to evaluate 10 seconds (or a specific time interval) of electrical activity of the heart so a physician can determine the condition of a patient's heart. The ECG Monitoring Equipment pipeline market research report provides comprehensive information about the ECG Monitoring Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials...
-
Company Profile
![]()
Recursion Pharmaceuticals Inc – Company Profile
Recursion Pharmaceuticals Inc (Recursion) is an artificial intelligence (AI)-driven biopharmaceutical company. It provides products that include a Robotics Platform, Recursion Operating System. Recursion has the pipeline disease model which includes Phase II Candidate: Cerebral Cavernous Malformation, Phase I Candidate: Neurofibromatosis Type 2, Phase I Candidate: Familial Adenomatous Polyposis, Phase I Candidate: GM2 Gangliosidosis. The company also offers target discovery and lead optimization services to its partner companies for furthering their clinical investigation. Recursion is headquartered in Salt Lake City, Utah,...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.